Puma Biotechnology Competitors and Similar CompaniesClear all
Puma Biotechnology's competitors and similar companies include ImmunoGen, Oncopeptides and Ascendis Pharma.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology. | ||
Founding Date | Founding Date 2010 | Founding Date 1981 | Founding Date 2000 | Founding Date 2007 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Los Angeles, US HQ | Locations Waltham, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US | Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US |
Employees | Employees 27214% decrease | Employees 277161% increase | Employees 678% increase | Employees 879 |
Valuation ($) | Valuation ($) 130 m | Valuation ($) 8.7 b | Valuation ($) 44.7 m | Valuation ($) 8.7 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $235.6m (FY, 2023) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) kr35.2m (FY, 2023) | Revenue (est.) €266.7m (FY, 2023) |
Cost of goods | Cost of goods $62.7m (FY, 2023) | Cost of goods $176k (FY, 2022) | Cost of goods (kr1.1m) (FY, 2023) | Cost of goods €41.9m (FY, 2023) |
Gross profit | Gross profit $173m (FY, 2023) | Gross profit $108.6m (FY, 2022) | Gross profit kr42.6m (FY, 2023) | Gross profit €224.8m (FY, 2023) |
Net income | Net income $21.6m (FY, 2023) | Net income ($222.9m) (FY, 2022) | Net income (kr249.1m) (FY, 2023) | Net income (€481.4m) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised $ 172m | Total funding raised $ 56m | Total funding raised N/A | Total funding raised $ 85.8m |
For sources of this data, please see the company profile
View Company Profiles
ImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company
Oncopeptides
HQ
Stockholm, SE
Employees
67↑ 8% increase
Oncopeptides is a clinical development pharmaceutical company.
View companyAscendis Pharma
HQ
Hellerup, DK
Employees
879
Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.
View company